Willem Koetse

Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial

Josef S Smolen, Paul Emery, Gianfranco Ferraccioli et al. · Annals of the Rheumatic Diseases · 2014 · 111 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy of Epratuzumab, an Anti‐<scp>CD</scp>22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome

Jacques‐Eric Gottenberg, Thomas Dörner, Hendrika Bootsma et al. · Arthritis & Rheumatology · 2018 · 70 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Assessing the long-term impact of drug court participation on recidivism with generalized estimating equations

Christopher Krebs, Christine Lindquist, Willem Koetse et al. · Drug and Alcohol Dependence · 2007 · 67 citations · Full text

Law, Criminal Law, Criminology +11

The Impact of Residential and Nonresidential Drug Treatment on Recidivism Among Drug-Involved Probationers

Christopher Krebs, Kevin J. Strom, Willem Koetse et al. · Crime & Delinquency · 2008 · 32 citations

Law, Criminal Law, Criminology +17

A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol

Jeffrey R. Curtis, Melvin Churchill, Alan Kivitz et al. · Arthritis & Rheumatology · 2015 · 28 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17